We are live on ! Find out more
INKT icon

MiNK Therapeutics
INKT

34 hedge funds and large institutions have $1.06M invested in MiNK Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $800K → $1.06M (+$260K)

0.08% more ownership

Funds ownership: 0.21% → 0.29% (+0.08%)

0% more funds holding

Funds holding: 34 → 34 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
34
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LF
Longbow Finance
Switzerland
+$174K
2
Citadel Advisors
Citadel Advisors
Florida
+$44K
3
HighTower Advisors
HighTower Advisors
Illinois
+$36K
4
Renaissance Technologies
Renaissance Technologies
New York
+$35.8K
5
Jane Street
Jane Street
New York
+$19.2K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$25.3K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$7.84K
3
Bank of America
Bank of America
North Carolina
-$4.84K
4
BlackRock
BlackRock
New York
-$4.22K
5
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$3.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$309 -$115 -11 -28%
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
$198 – – –
GPFA
28
Game Plan Financial Advisors
Ohio
$182 +$177 +17 New
JP Morgan Chase
29
JP Morgan Chase
New York
$115 – – –
Fidelity Investments
30
Fidelity Investments
Massachusetts
$100 +$31 +3 +50%
SN
31
Sittner & Nelson
Oregon
$62 – – –
KFI
32
Key Financial Inc
Pennsylvania
$46 – – –
S
33
SignatureFD
Georgia
$14 -$10 -1 -50%
HIA
34
Harbor Investment Advisory
Maryland
$5 – – –
AF
35
Allworth Financial
California
$3 – – –
ASN
36
Advisory Services Network
Georgia
$1 – – –
UOC
37
UBS O'Connor
Illinois
– -$25.3K -2,159 Closed
Lazard Asset Management
38
Lazard Asset Management
New York
– -$1K -129 Closed
QCG
39
Quadrant Capital Group
Ohio
– -$80 -7 Closed
LC
40
Lindbrook Capital
California
– -$15 -1 Closed
PA
41
Parallel Advisors
California
– -$11 -1 Closed
1
2

INKT Hedge Fund Activity: Q4 2023 in Review

34 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in MiNK Therapeutics (INKT) for Q4 2023, worth a combined $1.06M — up 32% from $800K a quarter earlier.

Fund positioning in INKT was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 9 trimmed.

The largest buyer was Longbow Finance, opening a new position worth an estimated $174K. The largest seller was UBS O'Connor, exiting entirely with an estimated $25.3K sold.

  • 34 institutional investors held MiNK Therapeutics (INKT) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $1.06M of MiNK Therapeutics stock for Q4 2023, up 32% quarter-over-quarter.
  • 5 funds opened new MiNK Therapeutics positions in Q4 2023 and 5 closed out, a net change of 0 holders.
  • The largest MiNK Therapeutics buyer in Q4 2023 was Longbow Finance, an estimated $174K added.
  • The largest MiNK Therapeutics seller in Q4 2023 was UBS O'Connor, an estimated $25.3K sold.

Based on aggregated 13F filings for Q4 2023.